Lynn Dorsey Bleil

FOLD

Lynn Dorsey Bleil serves as Director at Amicus Therapeutics, Inc. (FOLD). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$250.0K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$250.0K

Companies Traded

FOLD

Active Period

May 2021

1 total trades

Most Recent

Buy FOLD

May 27, 2021 · $250.0K

Lynn Dorsey Bleil's Insider Trading at Amicus Therapeutics, Inc. (FOLD)

Buys

1 · $250.0K

Sells

0 · $0.00

Total Shares Bought

28,605

Total Shares Sold

FOLD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 27, 2021↗	Buy	28,605	$8.74	$250.0K	50,310

Related Insiders

Bradley L Campbell

director, officer: President and CEO

FOLDSell · Mar 2, 2026

David Michael Clark

Chief People Officer

FOLDSell · Dec 19, 2025

Bradley L Campbell

President and CEO

FOLDSell · Dec 15, 2025

Ellen Rosenberg

Chief Legal Officer

FOLDSell · Nov 26, 2025

Jeff Castelli

Chief Development Officer

FOLDSell · Nov 24, 2025

Explore More Insider Trading Data

FOLD Insider Trading Activity

View all insider trades at Amicus Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity